Can the Polymerase Chain Reaction Be Used to Direct Therapy?
- 1 January 1993
- journal article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 10 (sup1) , 151-152
- https://doi.org/10.3109/10428199309149128
Abstract
(1993). Can the Polymerase Chain Reaction Be Used to Direct Therapy? Leukemia & Lymphoma: Vol. 10, No. sup1, pp. 151-152.Keywords
This publication has 7 references indexed in Scilit:
- All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatmentBlood, 1991
- Immunologic Purging of Marrow Assessed by PCR before Autologous Bone Marrow Transplantation for B-Cell LymphomaNew England Journal of Medicine, 1991
- Use of the polymerase chain reaction to monitor the effectiveness of ex vivo tumor cell purgingBlood, 1991
- Detection of Minimal Residual Cells Carrying the t(14;18) by DNA Sequence AmplificationScience, 1987
- Analysis of enzymatically amplified β-globin and HLA-DQα DNA with allele-specific oligonucleotide probesNature, 1986
- Detection of clonal excess in lymphoproliferative disease by kappa/lambda analysis: correlation with immunoglobulin gene DNA rearrangementBlood, 1986
- The Chromosomal Basis of Human NeoplasiaScience, 1983